Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice (original) (raw)

• Biju MP, Neumann AK, Bensinger SJ, Johnson RS, Turka LA, Haase VH . (2004). Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes. Mol Cell Biol 24: 9038–9047.
  Article CAS Google Scholar
• Bindra RS, Vasselli JR, Stearman R, Linehan WM, Klausner RD . (2002). VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells. Cancer Res 62: 3014–3019.
  CAS Google Scholar
• Chavez JC, Baranova O, Lin J, Pichiule P . (2006). The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J Neurosci 26: 9471–9481.
  Article CAS Google Scholar
• Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M . (2004). The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 18: 901–911.
  Article CAS Google Scholar
• Flamme I, Krieg M, Plate KH . (1998). Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2alpha. Am J Pathol 153: 25–29.
  Article CAS Google Scholar
• Gijtenbeek JM, Boots-Sprenger SH, Franke B, Wesseling P, Jeuken JW . (2005). Cyclin D1 genotype and expression in sporadic hemangioblastomas. J Neurooncol 74: 261–266.
  Article CAS Google Scholar
• Gruber M, Hu CJ, Johnson RS, Brown EJ, Keith B, Simon MC . (2007). Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci USA 104: 2301–2306.
  Article CAS Google Scholar
• Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J et al. (2005). Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9: 617–628.
  Article CAS Google Scholar
• Haase VH, Glickman JN, Socolovsky M, Jaenisch R . (2001). Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc Natl Acad Sci USA 98: 1583–1588.
  Article CAS Google Scholar
• Holmquist-Mengelbier L, Fredlund E, Lofstedt T, Noguera R, Navarro S, Nilsson H et al. (2006). Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 10: 413–423.
  Article CAS Google Scholar
• Kapitsinou PP, Haase VH . (2008). The VHL tumor suppressor and HIF: insights from genetic studies in mice. Cell Death Differ 15: 650–659.
  Article CAS Google Scholar
• Maher ER, Kaelin Jr WG . (1997). von Hippel-Lindau disease. Medicine (Baltimore) 76: 381–391.
  Article CAS Google Scholar
• McGrath FP, Gibney RG, Morris DC, Owen DA, Erb SR . (1992). Case report: multiple hepatic and pulmonary haemangioblastomas—a new manifestation of von Hippel-Lindau disease. Clin Radiol 45: 37–39.
  Article CAS Google Scholar
• Rankin EB, Biju MP, Liu Q, Unger TL, Rha J, Johnson RS et al. (2007). Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 117: 1068–1077.
  Article CAS Google Scholar
• Rankin EB, Giaccia AJ . (2008). The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15: 678–685.
  Article CAS Google Scholar
• Rankin EB, Higgins DF, Walisser JA, Johnson RS, Bradfield CA, Haase VH . (2005). Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice. Mol Cell Biol 25: 3163–3172.
  Article CAS Google Scholar
• Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL et al. (2005). Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 25: 5675–5686.
  Article CAS Google Scholar
• Rothhammer T, Bataille F, Spruss T, Eissner G, Bosserhoff AK . (2007). Functional implication of BMP4 expression on angiogenesis in malignant melanoma. Oncogene 26: 4158–4170.
  Article CAS Google Scholar
• Vortmeyer AO, Gnarra JR, Emmert-Buck MR, Katz D, Linehan WM, Oldfield EH et al. (1997). von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol 28: 540–543.
  Article CAS Google Scholar
• White P, Brestelli JE, Kaestner KH, Greenbaum LE . (2005). Identification of transcriptional networks during liver regeneration. J Biol Chem 280: 3715–3722.
  Article CAS Google Scholar
• Zatyka M, Da Silva NF, Clifford SC, Morris MR, Wiesener MS, Eckardt KU et al. (2002). Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease. Cancer Res 62: 3803–3811.
  CAS Google Scholar